North York Research Inc

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Psoriasis2 trials
• Atopic dermatitis (eczema)1 trial
• Hidradenitis suppurativa1 trial
• Vitiligo1 trial

Phase

• Phase 34 trials
• Phase 21 trial

Status

• Completed3 trials
• Active, not recruiting2 trials

Lead sponsor

• Janssen Research & Development, LLC2 trials
• Eli Lilly and Company1 trial
• Incyte Corporation1 trial
• Zura Bio Inc1 trial

Running trials

• Active, not recruiting

  Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense

  NCT06993610· Phase 2· Zura Bio Inc· Source

• Active, not recruiting

  A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1)

  NCT06113445· Phase 3· Incyte Corporation· Source

Closed trials

• Completed

  Study of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area Moderate Plaque Psoriasis

  NCT06039189· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis

  NCT05272150· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)

  NCT04392154· Phase 3· Eli Lilly and Company· Source